Background
==========

Hypospadias is a common congenital malformation of the genitourinary system in children, characterized by abnormal distribution of urethral orifice and circumcision \[[@b1-medscimonit-24-8984]\]. The etiology of hypospadias is unclear \[[@b2-medscimonit-24-8984],[@b3-medscimonit-24-8984]\], but the biological activity of urethral plate fibroblasts (UPF) is typically affected \[[@b4-medscimonit-24-8984],[@b5-medscimonit-24-8984]\]. Finasteride is a 4-nitrogen steroid hormone compound commonly used in treatment of benign prostatic hyperplasia \[[@b6-medscimonit-24-8984]\]. 5-α reductase is an enzyme necessary for the conversion of testosterone to 5α-dihydrotestosterone (DHT), while finasteride belongs to type II 5-α reductase inhibitor, which can block the transformation of testosterone to DHT and finally influence the DHT level \[[@b7-medscimonit-24-8984]\]. Finasteride can affect the development of genital organs \[[@b8-medscimonit-24-8984]\]. Finasteride administered to pregnant rats develop malformation of the urinary system, with hypospadias in male embryos \[[@b9-medscimonit-24-8984]\]. However, its mechanisms are still largely unknown.

The mitogen-activated protein kinase (MAPK) signaling pathway is a serine/threonine protein kinase pathway through which eukaryotic cells transduce extracellular signals into the cytoplasm \[[@b10-medscimonit-24-8984]\]. The MAPK signaling pathway was found to be abundant in the signal transduction pathway in hypospadias, based on whole-genome chip analysis \[[@b10-medscimonit-24-8984]\]. Lai et al. found that activation of the MAPK pathway stimulated steroid production, proving that the MAPK pathway is involved in secretion of sex hormones \[[@b11-medscimonit-24-8984]\]. Extracellular signal-regulated kinase (ERK) is an important member of the MAPK signaling pathway. Through phosphorylating its substrates, ERK takes part in the regulation of cell proliferation, stress, differentiation, apoptosis, and inflammation \[[@b12-medscimonit-24-8984],[@b13-medscimonit-24-8984]\]. Abnormalities of the ERK pathway can lead to neurological and developmental diseases. However, the relationship between urinary genitalia development and the ERK signaling pathway is still unclear \[[@b14-medscimonit-24-8984]--[@b16-medscimonit-24-8984]\].

Besides their actions as structural components, fibroblasts also play a critical role in immune response to tissue injury. The uncontrolled proliferation and a huge release of growth factor from fibroblasts can induce pathological changes \[[@b17-medscimonit-24-8984],[@b18-medscimonit-24-8984]\]. In this study, we established hypospadias in rats using finasteride and investigated the relationship between proliferation of UPFs and the MAPK/ERK signaling pathway. This study aimed to provide an experimental basis for clarifying the mechanisms involved in the occurrence and development of hypospadias.

Material and Methods
====================

Animals and model
-----------------

We obtained 20 female SD rats and 20 male rats (SPF grade, weight: \~150 g) from the Experimental Animal Center of Nantong University. All experimental procedures were approved by the Ethics Committee of Guizhou Provincial People's Hospital (2016195). After 1 week of adaptation, a female rat and a male rat were placed in a metabolic cage. In the morning, a suppository in the metabolic cage was observed to determine conception. The female rats with a suppository were put together, and the day was marked as day 0 of pregnancy. We randomly divided 20 pregnant rats into 4 groups: a normal control group, a 10 mg/kg finasteride group, a 50 mg/kg finasteride group, and a 100 mg/kg finasteride group. Finasteride tablets (MSD International GmbH LLC) were administered intragastrically to rats on the 8th day to the 16^th^ day according to the corresponding doses to establish hypospadias as previously described \[[@b19-medscimonit-24-8984]\]. On the 18^th^ day, the rats were killed and dissected.

The pregnant rats were weighed and anesthetized with isoflurane. Thereafter, abdominal hair was shaved and pregnant rats were fixed on the operating table and disinfected with iodophor. The abdomen was opened using surgical scissors, the whole uterus was gently exposed and was cut off with the placenta on a clean table. The amniotic membrane was opened with a carefully disinfected apparatus; the fetal rats were taken out gently and the umbilical cord was cut gently. The anal genitals distance (AGD) was measured, and testicles and penis were obtained under a stereoscopic microscope.

Hematoxylin Eosin (HE) staining
-------------------------------

The urethral tissues were rinsed for several hours, then dehydrated, embedded, and sliced. The paraffin sections were dewaxed and hydrated. The sections were stained with HE solution for 3 min and images were taken by light microscopy.

Preparation of urethral plate fibroblasts
-----------------------------------------

In the aseptic condition, urethral tissue of the fetal rats was taken out from the control and the modeled rats (10 mg/kg finasteride), and the tissues were washed with PBS 5 times. A sterile surgical scalpel was used to scrape the tissue around the urethra and then we cut the tissue into 2 mm x 2 mm pieces using ophthalmic scissors. The tissue was cultivated by direct adherent culture methods to culture fibroblasts *in vitro* in a 37°C CO~2~ incubator for 4 h. After full adherence, 5 mL of Dulbecco's modified Eagle's medium containing 10% fetal bovine serum was added into the culture bottle and the medium was refreshed every 3 day. When the cell confluence reached 80%, the tissues were removed and the cells were digested by 0.25% trypsin.

The mounted cells were washed with PBS 3 times and fixed in 4% polyformaldehyde for 15 min at room temperature, blocked in 5% BSA (Solarbio) at room temperature for 30 min, and then incubated with anti-vimentin antibody (CST) at 4°C overnight. After washing in PBS, the cells were incubated with Alexa Fluor 593 goat anti-rabbit IgG (1: 200, Life Technologies, Carlsbad, CA, USA) for 30 min at room temperature. Images were taken under fluorescence microscopy (BX51, Olympus, Japan). DAPI was used to stain the nuclei.

UPFs were divided into 4 groups: a normal control group, a model group, a model + MAPK inhibitor group, and a model + ERK inhibitor group. Equal numbers of UPFs (2×10^4^/mL) were placed on 96-well plates. After cell confluence attained 80%, serum-free medium was used to synchronize the cells for 24 h. After treatment with MAPK inhibitor or ERK inhibitor for 24 h, cell viability, apoptosis, cell cycle distribution, and protein expression were assessed.

Cell counting kit assay
-----------------------

After treatment with MAPK inhibitor (SB203580, 0.5 μM) (Tocris) or ERK inhibitor (SCH772984, 4 nM) (Tocris) for 24 h, 10 μL medium with the Cell Counting Kit (CCK)-8 (Gibco) was added into each well. After an additional 4-h incubation in a CO~2~ incubator at 37°C, the absorbance was detected by a microplate reader (Thermo Fisher Scientific) at 490 nm. Cell viability was defined by optical density (OD) values.

Flow cytometry
--------------

After treatment with MAPK inhibitor or ERK inhibitor for 24 h, 5×10^5^ cells were collected for Annexin V-fluorescein isothiocyanate/propidium iodide (PI) staining (cat. no. 70-AP101-100; MultiSciences, Hangzhou, China) and the proportion of apoptotic cells was detected within 1 h using a FACSCalibur flow cytometer (NovoCyte™, ACEA Biosciences) (Ex=488 nm; Em=530 nm) and data were analyzed using CellQuest Pro 5.1 (BD Biosciences, Franklin Lakes, NJ, USA). For cell cycle analysis, the cells were collected for PI staining (cat. no. 70-CCS013; MultiSciences, Hangzhou, China) for 30 min at room temperature. The Cell Cycle platform in FlowJo 10 software was used to analyze the cell cycle distribution.

Quantitative real-time PCR (QRT-PCR)
------------------------------------

After treatment with MAPK inhibitor or ERK inhibitor for 24 h, 5×10^5^ cells were obtained for QRT-PCR. mRNA was extracted using a TRIzol reagent kit (Invitrogen). Subsequently, total mRNA was transcribed into cDNA using reverse transcription kits according to the manufacturer's instructions (Takara Biotechnology Co., Dalian, China). Fluorescence QRT-PCR was utilized to detect expression levels of the targeted genes using cDNA as a template following treatment with DNA polymerase (catalog no. EP0041; Thermo Fisher Scientific) as follows: denaturation at 95°C for 45 s, annealing at 60°C for 45 s, and extension at 72°C for 60 s for 36 cycles. The target gene expression was normalized to GAPDH. The primers were synthesized by Shanghai Sangon (Shanghai, China) ([Table 1](#t1-medscimonit-24-8984){ref-type="table"}).

Western blot analysis
---------------------

The cells were treated with MAPK or ERK inhibitor for 24 h and 5×10^5^ cells were collected for Western blot analysis. Protein (20 μg) was extracted from the treated cells, run on sodium-dodecyl sulfate-polyacrylamide gels (10%), and transferred to nitrocellulose membranes. The membranes were blocked by 5% non-fat milk for 2 h at room temperature. The following primary antibodies were used for overnight incubation at 4°C: anti-caspase-3 (1: 1000, bs-0081R, Bioss, Beijing, China), anti-P53 (1: 2000, Cell Signaling), anti-p-MAPK14 (1: 1000, bs-5476R, Bioss, Beijing, China), anti-MAPK14 (1: 1000, bs-28027R, Bioss, Beijing, China), anti-MEK1 (1: 1000, ABclonal), and anti-p-MEK1 (1: 1000, ABclonal). After washing, the membranes were incubated with the secondary antibody (1: 100, ab131368, Abcam) for 2 h at room temperature. An Enhanced Chemiluminescence kit (No. RPN2133; GE Healthcare Life Sciences, Chicago, IL, USA) was added to the membrane prior to visualization with a gel imaging system (Thermo Fisher Scientific).

Statistical analysis
--------------------

The data were expressed as mean and standard deviation (SD). Statistical significance was calculated by one-way analysis of variance (ANOVA) with Newman-Keuls as the post hoc test (SPSS 17.0, IBM, Armonk, NY, USA). Parametric variables were described using frequency statistics and analyzed by the chi-squared test (χ^2^). P\<0.05 was considered statistically significant.

Results
=======

Finasteride caused hypospadias in male fetal rats
-------------------------------------------------

Compared with the normal control group, the anal genitals distance (AGD) in the finasteride groups was shortened ([Table 2](#t2-medscimonit-24-8984){ref-type="table"}), and the difference between finasteride (10 mg/kg or 50 mg/kg) group and control group was statistically significant (P\<0.05). The numbers of male rats and weight of the rats in each group were comparable. The numbers of hypospadias rats were significantly elevated in finasteride groups (10 mg/kg, 50 mg/kg, 100 mg/kg) compared with control (P\<0.05). The rate of hypospadias was significantly increased in finasteride-treated groups (10 mg/kg, 50 mg/kg, 100 mg/kg) compared with control (P\<0.05).

HE staining showed that the size of the cavernous sinus of the normal control group was relatively uniform, and the tissue layers between the white membrane and skin were abundant and loose ([Figure 1](#f1-medscimonit-24-8984){ref-type="fig"}). Rats in the finasteride groups showed more penile dysplasia in comparison with the normal control group, among which the 10 mg/kg finasteride group showed the most serious abnormality. Rats in the finasteride groups showed few fibrous connective tissues without white membrane structure. The urethral tissue in the finasteride groups was thin and relatively compact.

Proliferation of urethral plate fibroblasts was attenuated by MAPK inhibitor or ERK inhibitor
---------------------------------------------------------------------------------------------

The UPF were identified by immunofluorescence. As shown in [Figure 2A](#f2-medscimonit-24-8984){ref-type="fig"}, the red staining shows the target protein and the blue staining is the nucleus. The results showed that most of the cells expressed Vimentin specifically, which proved that the UPF were successfully separated.

Proliferation of UPF in the model group was higher than that of the control group ([Figure 2B](#f2-medscimonit-24-8984){ref-type="fig"}), and the difference was statistically significant (P\<0.05). Compared with the model group, MAPK inhibitor or ERK inhibitor significantly reduced the cell proliferation, and the difference was statistically significant (P\<0.05). By contrast, there was no statistically significant difference between the ERK inhibitor and MAPK inhibitor groups (P\>0.05).

Apoptosis of urethral plate fibroblasts was enhanced by MAPK inhibitor or ERK inhibitor
---------------------------------------------------------------------------------------

Compared with the normal control group, the model group showed lower apoptotic rate, and the difference was statistically significant (P\<0.05) ([Figure 3](#f3-medscimonit-24-8984){ref-type="fig"}). Compared with the model group, apoptotic rates in the MAPK inhibitor group and ERK inhibitor group were higher, and the difference was statistically significant (P\<0.05). Among them, the apoptotic rate of ERK inhibitor group was the highest, and the difference was statistically significant (*vs.* MAPK, P\<0.05).

Cell cycling of urethral plate fibroblasts was attenuated by MAPK inhibitor or ERK inhibitor
--------------------------------------------------------------------------------------------

Compared with the control group, the cell numbers in G1 and S phases in the model group was higher, while cell numbers in G2 phase were lower (P\<0.05) ([Figure 4](#f4-medscimonit-24-8984){ref-type="fig"}). By contrast, MAPK inhibitor or ERK inhibitor attenuated the abnormal cell cycle distribution (*vs.* model, P\<0.05). There was no significant difference between the ERK inhibitor group and MAPK inhibitor group (P\>0.05).

Apoptosis-related gene expression was enhanced by MAPK inhibitor or ERK inhibitor
---------------------------------------------------------------------------------

As compared with the control group, the expression of caspase 3 and P53 at mRNA level in the cells of the model group was significantly reduced. By contrast, MAPK inhibitor and ERK inhibitor significantly attenuated the effect of finasteride (P\<0.05). Caspase 3 and P53 in the MAPK inhibitor and ERK inhibitor groups were comparable ([Figure 5](#f5-medscimonit-24-8984){ref-type="fig"}).

Compared with the control group, the expression of p-MAPK14/MAPK14 in the model group was promoted. By contrast, a MAPK inhibitor and an ERK inhibitor significantly reduced P-MAPK14/MAPK14 (*vs.* model, P\<0.05). The expression of p-MEK1/MEK1, caspase 3, and P53 were reduced in the model group but were promoted in the MAPK inhibitor and ERK inhibitor groups ([Figure 6](#f6-medscimonit-24-8984){ref-type="fig"}).

Discussion
==========

Hypospadias is a congenital malformation of the urethral tissue, while finasteride is recognized as a drug that can induce hypospadias in male embryos. The effect is mainly by blocking the conversion of testosterone to DHT and reducing the DHT level. Through screening different doses of finasteride, hypospadias was also identified by HE staining. We found that the heterotopic urethral cavernosum was abundant when the dose of finasteride was 10 mg/kg, which indicated that the animal model of congenital hypospadias was successfully established. After that, the UPF were obtained from normal control and modeled rats, and the results of immunofluorescence showed that most of the cells expressed vimentin specifically, which proved that UPF were successfully collected.

Activation of the MAPK/ERK signaling pathway can promote gene expression and change the cellular physiological activities, including differentiation and apoptosis \[[@b20-medscimonit-24-8984],[@b21-medscimonit-24-8984]\]. In the present study, the proliferation and apoptosis of UPF was detected after treatment of a MAPK inhibitor and an ERK inhibitor, respectively. We found that the proliferation was promoted in UPF obtained from modeled rats, which supports that uncontrolled proliferation of urethral plate fibroblasts might be an important cause of hypospadias \[[@b22-medscimonit-24-8984],[@b23-medscimonit-24-8984]\]. To verify the results of proliferation, flow cytometry was used to detect apoptosis of the UPF in each group. Interestingly, apoptosis was reduced in the UPF obtained from modeled rats. Besides the reduced apoptosis, the cell cycling of UPF was also detected. Our results demonstrated that the cells in G1 and S phases were enhanced in the model group. Collectively, the proliferation activity of the UPF in the hypospadias group was higher than that in the normal control group, which might be caused by reduction of apoptosis and change of cell cycle. Importantly, the MAPK inhibitor and the ERK inhibitor effectively inhibited the proliferation of UPF. Moreover, apoptosis was promoted after MAPK and ERK inhibitor treatment. These results suggest that hypospadias has a relationship with the MAPK/ERK signaling pathway, which may be caused by the inhibition of cell apoptosis and enhanced cell cycling.

Apoptosis is the main form of programmed cell death in normal physiological states, and there is an important relationship between apoptosis and normal development of the urethra system. Abnormal apoptosis may lead to abnormal development of the urethral system \[[@b24-medscimonit-24-8984]\]. The MAPK/ERK signaling pathway is involved in the processes of cell differentiation, proliferation, development, and apoptosis \[[@b25-medscimonit-24-8984]--[@b27-medscimonit-24-8984]\]. In the present study, the expression of P-MAPK14/MAPK14 and p-MEK1/MEK1 was detected, and the results demonstrated that the relative expression of P-MAPK14/MAPK14 in the cells of the model group was upregulated, while the amount of p-MEK1/MEK1 expression decreased simultaneously compared with the control group. In contrast, the relative expression of P-MAPK14/MAPK14 in the MAPK inhibitor group and the ERK inhibitor group was reduced accordingly, while the p-MEK1/MEK1 expression increased. These results suggest that apoptosis of UPF in the hypospadias group is related to the level of P-MAPK14/MAPK14 and p-MEK1/MEK1, and show that apoptosis can be promoted by downregulation of MAPK14 and upregulation of MEK1.

Caspase 3 belongs to a class of specific proteolytic enzymes in the caspase family and is one of the most important effectors of apoptosis \[[@b28-medscimonit-24-8984],[@b29-medscimonit-24-8984]\]. Caspase in the cytoplasm receives the apoptosis signal only when cells undergo apoptosis, and caspase activates inactive zymogen to active caspases \[[@b30-medscimonit-24-8984],[@b31-medscimonit-24-8984]\]. In the present study, the expression of caspase 3 in each group of UPF was detected. The results showed that the expression of caspase 3 in the model group was reduced, while the MAPK inhibitor and the ERK inhibitor significantly upregulated the caspase 3 expression. These results reveal that the MAPK signaling pathway is related to apoptosis of UPF through regulating expression of caspase 3.

P53 is an important cyclin regulatory factor that mainly participates in cell proliferation by regulating G1 and S phases \[[@b32-medscimonit-24-8984]\]. In the present study, the expression of P53 of UPF was detected. The results showed that the expression of P53 in the model group was reduced, while the MAPK inhibitor and the ERK inhibitor significantly upregulated P53 expression. These results suggest that inhibition of the expression of MAPK or ERK affects apoptosis. Based upon previous publications \[[@b33-medscimonit-24-8984],[@b34-medscimonit-24-8984]\], the main downstream effectors of MAPK and ERK are different, in which caspase 3 is the main effective factor of MAPK, while P53 is the main effective factor of ERK. Based upon these data, MAPK/ERK could be a therapeutic target for the disease treatment, although *in vivo* evidence is still required.

Conclusions
===========

Our study reveals that the MAPK/ERK signaling pathway is involved in the regulation of proliferation, apoptosis, and cell cycling of UPFs. Excessive proliferation of UPFs might cause obstruction of the urethra plate, resulting in hypospadias. Nevertheless, *in vivo* experiments are still needed to confirm our findings.
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![Proliferation of urethral plate fibroblasts was attenuated by MAPK inhibitor or ERK inhibitor. (**A**) Identification of urethral plate fibroblasts by immunofluorescence. Scale bar: 100 μm; (**B**) CCK-8 assay of cell viability. Compared with control, \* P\<0.05; compared with model, ^\#^ P\<0.05.](medscimonit-24-8984-g002){#f2-medscimonit-24-8984}

![Apoptosis of urethral plate fibroblasts was enhanced by MAPK inhibitor or ERK inhibitor. (**A**) Representative image of flow cytometry. (**B**) Quantification data of the apoptosis. Compared with control, \* P\<0.05; compared with model, ^\#^ P\<0.05.](medscimonit-24-8984-g003){#f3-medscimonit-24-8984}

![Cell cycling of urethral plate fibroblasts was attenuated by MAPK inhibitor or ERK inhibitor. (**A**) Representative image of flow cytometry. (**B**) Quantification data of the cell numbers in G1, S, G2 phases. Compared with control, \* P\<0.05; compared with model, ^\#^ P\<0.05.](medscimonit-24-8984-g004){#f4-medscimonit-24-8984}

![Caspase-3 and P53 expression at mRNA level was enhanced by MAPK inhibitor or ERK inhibitor. Compared with control, \* P\<0.05; compared with model, ^\#^ P\<0.05.](medscimonit-24-8984-g005){#f5-medscimonit-24-8984}

![Apoptosis-related gene expression was enhanced by MAPK inhibitor or ERK inhibitor. (**A**) Representative blots of caspase-3, P53, p-MAPK14, and p-MEK. (**B**) Quantification data of p-MAPK14/MAPK14; (**C**) Quantification data of p-MEK1/MEK1; (**D**) Quantification data of caspase 3; (**E**) Quantification data of P53. Compared with control, \* P\<0.05; compared with model, ^\#^ P\<0.05.](medscimonit-24-8984-g006){#f6-medscimonit-24-8984}

###### 

The primer sequences.

  Genes         Primers (5′-3′)
  ------------- ----------------------
  Caspase 3-F   AAAGCCGAAACTCTTCATCA
  Caspase 3-R   GTCTCAATACCGCAGTCCAG
  P53-F         CTCCCCAACATCTTATCCG
  P53-R         ACAGGCACAAACACGAACC
  GAPDH-F       GCAAGTTCAACGGCACAG
  GAPDH-R       CGCCAGTAGACTCCACGAC

###### 

Finasteride caused hypospadias in male fetal rats.

                                         Control     Finasteride                                                                                                                     
  -------------------------------------- ----------- --------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------
  No. of pregnant rats (N)               5           5                                                               5                                                               5
  No. of male fetal                      12          10                                                              7                                                               5
  AGD in male fetal (mm)                 1.89±0.73   1.54±0.13[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}   1.38±0.21[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}   1.88±0.26
  Weight (g)                             1.38±0.29   1.50±0.12                                                       1.35±0.09                                                       1.5±0.07
  No. of male embryos with hypospadias   0           3[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}           4[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}           3[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}
  Rate of hypospadias                    0           30%[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}         57%[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}         60%[\*](#tfn2-medscimonit-24-8984){ref-type="table-fn"}

Compared with control,

P\<0.05.
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